Mouse models for immuno-oncology

Trends Cancer. 2023 Jul;9(7):578-590. doi: 10.1016/j.trecan.2023.03.009. Epub 2023 Apr 20.


Realizing the clinical promise of cancer immunotherapy is hindered by gaps in our knowledge of in vivo mechanisms underlying treatment response as well as treatment limiting toxicity. Preclinical in vivo model systems and technologies are required to address these knowledge gaps and to surmount the challenges faced in the clinical application of immunotherapy. Mice are commonly used for basic and translational research to support development and testing of immune interventions, including for cancer. Here, we discuss the advantages and the limitations of current models as well as future developments.

Keywords: cancer immunotherapy; collaborative cross mice; diversity outbred mice; genetically engineered mice; humanized mice; mouse model.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Immunotherapy
  • Medical Oncology
  • Mice
  • Neoplasms* / drug therapy
  • Translational Research, Biomedical